查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1459768

肿瘤营养市场（营养：肠内营养和肠外营养；配方：标准配方、元素配方和专业配方）- 全球行业分析、规模、份额、增长、趋势和预测，2023-2031 年

Oncology Nutrition Market (Nutrition: Enteral Nutrition and Parenteral Nutrition; and Formula: Standard Formula, Elemental Formula, and Specialized Formula) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 212 Pages | 商品交期: 2-10个工作天内

价格

肿瘤营养市场 - 报告范围

TMR 关于全球肿瘤营养市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球肿瘤营养市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球肿瘤营养市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解肿瘤营养市场。

市场概况
2022年市场价​​值 21 亿美元
2031 年市场价值 36 亿美元
CAGR 6.2%

该报告深入研究了全球肿瘤营养市场的竞争格局。全球肿瘤营养市场的主要参与者已经确定，并且每位参与者都根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球肿瘤营养市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：按癌症类型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按癌症类型，2017-2031
    • 头颈癌
    • 大肠直肠癌
    • 血液学 癌症
    • 摄护腺癌
    • 乳癌
    • 胃肠癌
    • 肺癌
    • 胰腺癌
    • 其他的
  • 市场吸引力：按癌症类型

第 7 章：全球市场分析与预测：依营养分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依营养分类，2017-2031
    • 肠内营养
    • 肠外营养
  • 市场吸引力：依营养分类

第 8 章：全球市场分析与预测：按公式

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依公式计算，2017-2031
    • 标准配方
    • 元素公式
    • 专业配方
  • 市场吸引力：按公式计算

第 9 章：全球市场分析与预测：按配销通路

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2017-2031
    • 住院营养
    • 门诊营养
  • 市场吸引力：按配销通路划分

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 11 章：北美市场分析与预测

第 12 章：欧洲市场分析与预测

第 13 章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • Danone SA
    • Pfizer Inc.
    • B. Braun Melsungen AG
    • Fresenius Kabi AG
    • Grifols SA
    • Baxter International, Inc.
    • Nestle SA
    • Abbott Laboratories
    • AbbVie, Inc.
    • Sichuan Kelun Pharmaceutical Co., Ltd.
Product Code: TMRGL46314

Oncology Nutrition Market - Scope of Report

TMR's report on the global oncology nutrition market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global oncology nutrition market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global oncology nutrition market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the oncology nutrition market.

Market Snapshot
Market Value in 2022US$ 2.1 Bn
Market Value in 2031US$ 3.6 Bn
CAGR6.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global oncology nutrition market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global oncology nutrition market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global oncology nutrition market.

The report delves into the competitive landscape of the global oncology nutrition market. Key players operating in the global oncology nutrition market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global oncology nutrition market profiled in this report.

Key Questions Answered in Global oncology nutrition Market Report:

  • What is the sales/revenue generated by oncology nutrition across all regions during the forecast period?
  • What are the opportunities in the global oncology nutrition market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Oncology Nutrition Market - Research Objectives and Research Approach

The comprehensive report on the global oncology nutrition market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global oncology nutrition market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global oncology nutrition market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Oncology Nutrition Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Oncology Nutrition Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Oncology Nutrition Market Analysis and Forecast, by Cancer Type

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Cancer Type, 2017-2031
    • 6.3.1. Head and Neck Cancer
    • 6.3.2. Colorectal Cancer
    • 6.3.3. Hematology Cancer
    • 6.3.4. Prostate Cancer
    • 6.3.5. Breast Cancer
    • 6.3.6. Gastrointestinal Cancer
    • 6.3.7. Lung Cancer
    • 6.3.8. Pancreatic Cancer
    • 6.3.9. Others
  • 6.4. Market Attractiveness, by Cancer Type

7. Global Oncology Nutrition Market Analysis and Forecast, by Nutrition

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Nutrition, 2017-2031
    • 7.3.1. Enteral Nutrition
    • 7.3.2. Parenteral Nutrition
  • 7.4. Market Attractiveness, by Nutrition

8. Global Oncology Nutrition Market Analysis and Forecast, by Formula

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Formula, 2017-2031
    • 8.3.1. Standard Formula
    • 8.3.2. Elemental Formula
    • 8.3.3. Specialized Formula
  • 8.4. Market Attractiveness, by Formula

9. Global Oncology Nutrition Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 9.3.1. Inpatient Nutrition
    • 9.3.2. Outpatient Nutrition
  • 9.4. Market Attractiveness, by Distribution Channel

10. Global Oncology Nutrition Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Oncology Nutrition Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Cancer Type, 2017-2031
    • 11.2.1. Head and Neck Cancer
    • 11.2.2. Colorectal Cancer
    • 11.2.3. Hematology Cancer
    • 11.2.4. Prostate Cancer
    • 11.2.5. Breast Cancer
    • 11.2.6. Gastrointestinal Cancer
    • 11.2.7. Lung Cancer
    • 11.2.8. Pancreatic Cancer
    • 11.2.9. Others
  • 11.3. Market Attractiveness, by Cancer Type
  • 11.4. Market Value Forecast, by Nutrition, 2017-2031
    • 11.4.1. Enteral Nutrition
    • 11.4.2. Parenteral Nutrition
  • 11.5. Market Attractiveness, by Nutrition
  • 11.6. Market Value Forecast, by Formula, 2017-2031
    • 11.6.1. Standard Formula
    • 11.6.2. Elemental Formula
    • 11.6.3. Specialized Formula
  • 11.7. Market Attractiveness, by Formula
  • 11.8. Market Value Forecast, by Distribution Channel
    • 11.8.1. Inpatient Nutrition
    • 11.8.2. Outpatient Nutrition
  • 11.9. Market Attractiveness, by Distribution Channel
  • 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Cancer Type
    • 11.11.2. By Nutrition
    • 11.11.3. By Formula
    • 11.11.4. By Distribution Channel
    • 11.11.5. By Country

12. Europe Oncology Nutrition Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Cancer Type, 2017-2031
    • 12.2.1. Head and Neck Cancer
    • 12.2.2. Colorectal Cancer
    • 12.2.3. Hematology Cancer
    • 12.2.4. Prostate Cancer
    • 12.2.5. Breast Cancer
    • 12.2.6. Gastrointestinal Cancer
    • 12.2.7. Lung Cancer
    • 12.2.8. Pancreatic Cancer
    • 12.2.9. Others
  • 12.3. Market Attractiveness, by Cancer Type
  • 12.4. Market Value Forecast, by Nutrition, 2017-2031
    • 12.4.1. Enteral Nutrition
    • 12.4.2. Parenteral Nutrition
  • 12.5. Market Attractiveness, by Nutrition
  • 12.6. Market Value Forecast, by Formula, 2017-2031
    • 12.6.1. Standard Formula
    • 12.6.2. Elemental Formula
    • 12.6.3. Specialized Formula
  • 12.7. Market Attractiveness, by Formula
  • 12.8. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.8.1. Inpatient Nutrition
    • 12.8.2. Outpatient Nutrition
  • 12.9. Market Attractiveness, by Distribution Channel
  • 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Cancer Type
    • 12.11.2. By Nutrition
    • 12.11.3. By Formula
    • 12.11.4. By Distribution Channel
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Oncology Nutrition Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Cancer Type, 2017-2031
    • 13.2.1. Head and Neck Cancer
    • 13.2.2. Colorectal Cancer
    • 13.2.3. Hematology Cancer
    • 13.2.4. Prostate Cancer
    • 13.2.5. Breast Cancer
    • 13.2.6. Gastrointestinal Cancer
    • 13.2.7. Lung Cancer
    • 13.2.8. Pancreatic Cancer
    • 13.2.9. Others
  • 13.3. Market Attractiveness, by Cancer Type
  • 13.4. Market Value Forecast, by Nutrition, 2017-2031
    • 13.4.1. Enteral Nutrition
    • 13.4.2. Parenteral Nutrition
  • 13.5. Market Attractiveness, by Nutrition
  • 13.6. Market Value Forecast, by Formula, 2017-2031
    • 13.6.1. Standard Formula
    • 13.6.2. Elemental Formula
    • 13.6.3. Specialized Formula
  • 13.7. Market Attractiveness, by Formula
  • 13.8. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.8.1. Inpatient Nutrition
    • 13.8.2. Outpatient Nutrition
  • 13.9. Market Attractiveness, by Distribution Channel
  • 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Cancer Type
    • 13.11.2. By Nutrition
    • 13.11.3. By Formula
    • 13.11.4. By Distribution Channel
    • 13.11.5. By Country/Sub-region

14. Latin America Oncology Nutrition Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Cancer Type, 2017-2031
    • 14.2.1. Head and Neck Cancer
    • 14.2.2. Colorectal Cancer
    • 14.2.3. Hematology Cancer
    • 14.2.4. Prostate Cancer
    • 14.2.5. Breast Cancer
    • 14.2.6. Gastrointestinal Cancer
    • 14.2.7. Lung Cancer
    • 14.2.8. Pancreatic Cancer
    • 14.2.9. Others
  • 14.3. Market Attractiveness, by Cancer Type
  • 14.4. Market Value Forecast, by Nutrition, 2017-2031
    • 14.4.1. Enteral Nutrition
    • 14.4.2. Parenteral Nutrition
  • 14.5. Market Attractiveness, by Nutrition
  • 14.6. Market Value Forecast, by Formula, 2017-2031
    • 14.6.1. Standard Formula
    • 14.6.2. Elemental Formula
    • 14.6.3. Specialized Formula
  • 14.7. Market Attractiveness, by Formula
  • 14.8. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.8.1. Inpatient Nutrition
    • 14.8.2. Outpatient Nutrition
  • 14.9. Market Attractiveness, by Distribution Channel
  • 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Cancer Type
    • 14.11.2. By Nutrition
    • 14.11.3. By Formula
    • 14.11.4. By Distribution Channel
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Oncology Nutrition Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Cancer Type, 2017-2031
    • 15.2.1. Head and Neck Cancer
    • 15.2.2. Colorectal Cancer
    • 15.2.3. Hematology Cancer
    • 15.2.4. Prostate Cancer
    • 15.2.5. Breast Cancer
    • 15.2.6. Gastrointestinal Cancer
    • 15.2.7. Lung Cancer
    • 15.2.8. Pancreatic Cancer
    • 15.2.9. Others
  • 15.3. Market Attractiveness, by Cancer Type
  • 15.4. Market Value Forecast, by Nutrition, 2017-2031
    • 15.4.1. Enteral Nutrition
    • 15.4.2. Parenteral Nutrition
  • 15.5. Market Attractiveness, by Nutrition
  • 15.6. Market Value Forecast, by Formula, 2017-2031
    • 15.6.1. Standard Formula
    • 15.6.2. Elemental Formula
    • 15.6.3. Specialized Formula
  • 15.7. Market Attractiveness, by Formula
  • 15.8. Market Value Forecast, by Distribution Channel, 2017-2031
    • 15.8.1. Inpatient Nutrition
    • 15.8.2. Outpatient Nutrition
  • 15.9. Market Attractiveness, by Distribution Channel
  • 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Cancer Type
    • 15.11.2. By Nutrition
    • 15.11.3. By Formula
    • 15.11.4. By Distribution Channel
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Danone S.A.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Pfizer Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. B. Braun Melsungen AG
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Fresenius Kabi AG
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Grifols S.A.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Baxter International, Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Nestle S.A.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Abbott Laboratories
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. AbbVie, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Sichuan Kelun Pharmaceutical Co., Ltd.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Oncology Nutrition Market Size (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 02: Global Oncology Nutrition Market Size (US$ Mn) Forecast, by Nutrition, 2017-2031
  • Table 03: Global Oncology Nutrition Market Size (US$ Mn) Forecast, by Formula, 2017-2031
  • Table 04: Global Oncology Nutrition Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 05: Global Oncology Nutrition Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Oncology Nutrition Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Oncology Nutrition Market Size (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 08: North America Oncology Nutrition Market Size (US$ Mn) Forecast, by Nutrition, 2017-2031
  • Table 09: North America Oncology Nutrition Market Size (US$ Mn) Forecast, by Formula, 2017-2031
  • Table 10: North America Oncology Nutrition Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 11: Europe Oncology Nutrition Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Oncology Nutrition Market Size (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 13: Europe Oncology Nutrition Market Size (US$ Mn) Forecast, by Nutrition, 2017-2031
  • Table 14: Europe Oncology Nutrition Market Size (US$ Mn) Forecast, by Formula, 2017-2031
  • Table 15: Europe Oncology Nutrition Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 16: Asia Pacific Oncology Nutrition Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Oncology Nutrition Market Size (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 18: Asia Pacific Oncology Nutrition Market Size (US$ Mn) Forecast, by Nutrition, 2017-2031
  • Table 19: Asia Pacific Oncology Nutrition Market Size (US$ Mn) Forecast, by Formula, 2017-2031
  • Table 20: Asia Pacific Oncology Nutrition Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 21: Latin America Oncology Nutrition Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Oncology Nutrition Market Size (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 23: Latin America Oncology Nutrition Market Size (US$ Mn) Forecast, by Nutrition, 2017-2031
  • Table 24: Latin America Oncology Nutrition Market Size (US$ Mn) Forecast, by Formula, 2017-2031
  • Table 25: Latin America Oncology Nutrition Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 26: Middle East & Africa Oncology Nutrition Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Oncology Nutrition Market Size (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 28: Middle East & Africa Oncology Nutrition Market Size (US$ Mn) Forecast, by Nutrition, 2017-2031
  • Table 29: Middle East & Africa Oncology Nutrition Market Size (US$ Mn) Forecast, by Formula, 2017-2031
  • Table 30: Middle East & Africa Oncology Nutrition Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Oncology Nutrition Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Oncology Nutrition Market Revenue (US$ Mn), by Cancer Type, 2022
  • Figure 03: Global Oncology Nutrition Market Value Share, by Cancer Type, 2022
  • Figure 04: Global Oncology Nutrition Market Revenue (US$ Mn), by Nutrition, 2022
  • Figure 05: Global Oncology Nutrition Market Value Share, by Nutrition, 2022
  • Figure 06: Global Oncology Nutrition Market Revenue (US$ Mn), by Formula, 2022
  • Figure 07: Global Oncology Nutrition Market Value Share, by Formula, 2022
  • Figure 08: Global Oncology Nutrition Market Value Share, by Distribution Channel, 2022
  • Figure 09: Global Oncology Nutrition Market Value Share, by Distribution Channel, 2022
  • Figure 10: Global Oncology Nutrition Market Value Share, by Region, 2022
  • Figure 11: Global Oncology Nutrition Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 12: Global Oncology Nutrition Market Value Share Analysis, by Cancer Type, 2022-2031
  • Figure 13: Global Oncology Nutrition Market Attractiveness Analysis, by Cancer Type, 2023-2031
  • Figure 14: Global Oncology Nutrition Market Value Share Analysis, by Nutrition, 2022-2031
  • Figure 15: Global Oncology Nutrition Market Attractiveness Analysis, by Nutrition, 2023-2031
  • Figure 16: Global Oncology Nutrition Market Value Share Analysis, by Formula, 2022-2031
  • Figure 17: Global Oncology Nutrition Market Attractiveness Analysis, by Formula, 2023-2031
  • Figure 18: Global Oncology Nutrition Market Revenue (US$ Mn), by Distribution Channel, 2022
  • Figure 19: Global Oncology Nutrition Market Value Share, by Distribution Channel, 2022
  • Figure 20: Global Oncology Nutrition Market Value Share Analysis, by Region, 2022-2031
  • Figure 21: Global Oncology Nutrition Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America Oncology Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 23: North America Oncology Nutrition Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 24: North America Oncology Nutrition Market Value Share Analysis, by Country, 2022-2031
  • Figure 25: North America Oncology Nutrition Market Value Share Analysis, by Cancer Type, 2022-2031
  • Figure 26: North America Oncology Nutrition Market Value Share Analysis, by Nutrition, 2022-2031
  • Figure 27: North America Oncology Nutrition Market Value Share Analysis, by Formula, 2022-2031
  • Figure 28: North America Oncology Nutrition Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 29: North America Oncology Nutrition Market Attractiveness Analysis, by Cancer Type, 2017-2031
  • Figure 30: North America Oncology Nutrition Market Attractiveness Analysis, by Nutrition, 2023-2031
  • Figure 31: North America Oncology Nutrition Market Attractiveness Analysis, by Formula, 2023-2031
  • Figure 32: North America Oncology Nutrition Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 33: Europe Oncology Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 34: Europe Oncology Nutrition Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 35: Europe Oncology Nutrition Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 36: Europe Oncology Nutrition Market Value Share Analysis, by Cancer Type, 2022-2031
  • Figure 37: Europe Oncology Nutrition Market Value Share Analysis, by Nutrition, 2022-2031
  • Figure 38: Europe Oncology Nutrition Market Value Share Analysis, by Formula, 2022-2031
  • Figure 39: Europe Oncology Nutrition Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 40: Europe Oncology Nutrition Market Attractiveness Analysis, by Cancer Type, 2023-2031
  • Figure 41: Europe Oncology Nutrition Market Attractiveness Analysis, by Nutrition, 2023-2031
  • Figure 42: Europe Oncology Nutrition Market Attractiveness Analysis, by Formula, 2023-2031
  • Figure 43: Europe Oncology Nutrition Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 44: Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 45: Asia Pacific Oncology Nutrition Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Asia Pacific Oncology Nutrition Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 47: Asia Pacific Oncology Nutrition Market Value Share Analysis, by Cancer Type, 2022-2031
  • Figure 48: Asia Pacific Oncology Nutrition Market Value Share Analysis, by Nutrition, 2022-2031
  • Figure 49: Asia Pacific Oncology Nutrition Market Value Share Analysis, by Formula, 2022-2031
  • Figure 50: Asia Pacific Oncology Nutrition Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 51: Asia Pacific Oncology Nutrition Market Attractiveness Analysis, by Cancer Type, 2023-2031
  • Figure 52: Asia Pacific Oncology Nutrition Market Attractiveness Analysis, by Nutrition, 2023-2031
  • Figure 53: Asia Pacific Oncology Nutrition Market Attractiveness Analysis, by Formula, 2023-2031
  • Figure 54: Asia Pacific Oncology Nutrition Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 55: Latin America Oncology Nutrition Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 56: Latin America Oncology Nutrition Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 57: Latin America Oncology Nutrition Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 58: Latin America Oncology Nutrition Market Value Share Analysis, by Cancer Type, 2022-2031
  • Figure 59: Latin America Oncology Nutrition Market Value Share Analysis, by Nutrition, 2022-2031
  • Figure 60: Latin America Oncology Nutrition Market Value Share Analysis, by Formula, 2022-2031
  • Figure 61: Latin America Oncology Nutrition Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 62: Latin America Oncology Nutrition Market Attractiveness Analysis, by Cancer Type, 2023-2031
  • Figure 63: Latin America Oncology Nutrition Market Attractiveness Analysis, by Nutrition, 2023-2031
  • Figure 64: Latin America Oncology Nutrition Market Attractiveness Analysis, by Formula, 2023-2031
  • Figure 65: Latin America Oncology Nutrition Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 66: Middle East & Africa Oncology Nutrition Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 67: Middle East & Africa Oncology Nutrition Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 68: Middle East & Africa Oncology Nutrition Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 69: Middle East & Africa Oncology Nutrition Market Value Share Analysis, by Cancer Type, 2022-2031
  • Figure 70: Middle East & Africa Oncology Nutrition Market Value Share Analysis, by Nutrition, 2022-2031
  • Figure 71: Middle East & Africa Oncology Nutrition Market Value Share Analysis, by Formula, 2022-2031
  • Figure 72: Middle East & Africa Oncology Nutrition Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 73: Middle East & Africa Oncology Nutrition Market Attractiveness Analysis, by Cancer Type, 2023-2031
  • Figure 74: Middle East & Africa Oncology Nutrition Market Attractiveness Analysis, by Nutrition, 2023-2031
  • Figure 75: Middle East & Africa Oncology Nutrition Market Attractiveness Analysis, by Formula, 2023-2031
  • Figure 76: Middle East & Africa Oncology Nutrition Market Attractiveness Analysis, by Distribution Channel, 2023-2031